Claims Pared In Dey, Sepracor IP Fight Over Brovana

By Christopher Norton

Law360, New York (March 18, 2010, 2:40 PM ET) -- Sepracor Inc. and Dey LP have agreed to dismiss a range of individual patent claims in their battle over Sepracor's rollout of chronic obstructive pulmonary disease drug Brovana.

Dey agreed Wednesday to drop prosecution of over 30 claims of one of the patents it asserted against Sepracor in the U.S. District Court for the Southern District of New York.

Sepracor, for its part, said it would drop its declaratory judgment counterclaims relating to those same claims of U.S. Patent Number 6,814,953.

The case remains pending with...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles